Follow
Jobert G. Barin
Jobert G. Barin
Research Associate, Johns Hopkins University School of Medicine, Dept. of Pathology, Div. of Immunology
Verified email at jhmi.edu
Title
Cited by
Cited by
Year
Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy
GC Baldeviano, JG Barin, MV Talor, S Srinivasan, D Bedja, D Zheng, ...
Circulation research 106 (10), 1646-1655, 2010
3642010
Etanercept plus standard therapy for Wegener's granulomatosis
Wegener's Granulomatosis Etanercept Trial (WGET) Research Group
New England Journal of Medicine 352 (4), 351-361, 2005
3642005
Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial
JH Stone
Arthritis & Rheumatism: Official Journal of the American College of …, 2003
3502003
Cardiac fibroblasts mediate IL-17A–driven inflammatory dilated cardiomyopathy
L Wu, SF Ong, MV Talor, JG Barin, GC Baldeviano, DA Kass, D Bedja, ...
Journal of Experimental Medicine 211 (7), 1449-1464, 2014
1802014
Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation
D Cihakova, JG Barin, M Afanasyeva, M Kimura, DL Fairweather, M Berg, ...
The American journal of pathology 172 (5), 1195-1208, 2008
1802008
Quantitative analysis of myocardial inflammation by flow cytometry in murine autoimmune myocarditis: correlation with cardiac function
M Afanasyeva, D Georgakopoulos, DF Belardi, AC Ramsundar, JG Barin, ...
The American journal of pathology 164 (3), 807-815, 2004
1632004
Macrophages participate in IL‐17‐mediated inflammation
JG Barin, GC Baldeviano, MV Talor, L Wu, SF Ong, F Quader, P Chen, ...
European journal of immunology 42 (3), 726-736, 2012
1332012
Design of the Wegener's granulomatosis etanercept trial (WGET)
TWR Group
Controlled clinical trials 23 (4), 450-468, 2002
1072002
Natural killer cells limit cardiac inflammation and fibrosis by halting eosinophil infiltration
SF Ong, DL Ligons, JG Barin, L Wu, MV Talor, N Diny, JA Fontes, ...
The American journal of pathology 185 (3), 847-861, 2015
902015
Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA)
MV Talor, JH Stone, J Stebbing, J Barin, NR Rose, CL Burek
Clinical & Experimental Immunology 150 (1), 42-48, 2007
892007
Eosinophil-derived IL-4 drives progression of myocarditis to inflammatory dilated cardiomyopathy
NL Diny, GC Baldeviano, MV Talor, JG Barin, SF Ong, D Bedja, AG Hays, ...
Journal of Experimental Medicine 214 (4), 943-957, 2017
862017
IL-33 independently induces eosinophilic pericarditis and cardiac dilation: ST2 improves cardiac function
ED Abston, JG Barin, D Cihakova, A Bucek, MJ Coronado, JE Brandt, ...
Circulation: Heart Failure 5 (3), 366-375, 2012
762012
Macrophage diversity in cardiac inflammation: a review
JG Barin, NR Rose, D Čiháková
Immunobiology 217 (5), 468-475, 2012
682012
Fatal eosinophilic myocarditis develops in the absence of IFN-γ and IL-17A
JG Barin, GC Baldeviano, MV Talor, L Wu, SF Ong, DL Fairweather, ...
The Journal of Immunology 191 (8), 4038-4047, 2013
662013
Macrophages and cardiac fibroblasts are the main producers of eotaxins and regulate eosinophil trafficking to the heart
NL Diny, X Hou, JG Barin, G Chen, MV Talor, J Schaub, SD Russell, ...
European journal of immunology 46 (12), 2749-2760, 2016
622016
Susceptibility to autoimmune myocarditis is associated with intrinsic differences in CD4+ T cells
P Chen, GC Baldeviano, DL Ligons, MV Talor, JG Barin, NR Rose, ...
Clinical & Experimental Immunology 169 (2), 79-88, 2012
592012
Iodination of murine thyroglobulin enhances autoimmune reactivity in the NOD.H2h4 mouse
JG Barin, MV Talor, RB Sharma, NR Rose, CL Burek
Clinical & Experimental Immunology 142 (2), 251-259, 2005
592005
The cardiac microenvironment instructs divergent monocyte fates and functions in myocarditis
X Hou, G Chen, W Bracamonte-Baran, HS Choi, NL Diny, J Sung, ...
Cell reports 28 (1), 172-189. e7, 2019
582019
Complete Freund's adjuvant induces experimental autoimmune myocarditis by enhancing IL‐6 production during initiation of the immune response
JA Fontes, JG Barin, MV Talor, N Stickel, J Schaub, NR Rose, D Čiháková
Immunity, inflammation and disease 5 (2), 163-176, 2017
552017
Pathogenic IL‐23 signaling is required to initiate GM‐CSF‐driven autoimmune myocarditis in mice
L Wu, NL Diny, SF Ong, JG Barin, X Hou, NR Rose, MV Talor, D Čiháková
European journal of immunology 46 (3), 582-592, 2016
522016
The system can't perform the operation now. Try again later.
Articles 1–20